Search

everythinglearnresearchcommunity

for

Search:↓

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Scalp pemphigus vulgaris can be effectively treated with low-dose prednisone and triamcinolone.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Corticosteroids may effectively regrow hair in Alopecia Totalis with manageable side effects.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Early diagnosis and comprehensive management improve life quality for Netherton syndrome patients.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.